26 related articles for article (PubMed ID: 15983626)
1. Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02.
Lawton CA; Bae K; Pilepich M; Hanks G; Shipley W
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):437-41. PubMed ID: 17881145
[TBL] [Abstract][Full Text] [Related]
2. Late radiotherapy toxicity after prostate cancer treatment: influence of hormonal therapy.
Jani AB; Gratzle J
Urology; 2005 Sep; 66(3):566-70. PubMed ID: 16140079
[TBL] [Abstract][Full Text] [Related]
3. Analysis of influence of age on acute and chronic radiotherapy toxicity in treatment of prostate cancer.
Jani AB; Parikh SD; Vijayakumar S; Gratzle J
Urology; 2005 Jun; 65(6):1157-62. PubMed ID: 15913725
[TBL] [Abstract][Full Text] [Related]
4. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
Ho AY; Burri RJ; Cesaretti JA; Stone NN; Stock RG
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):16-22. PubMed ID: 19289266
[TBL] [Abstract][Full Text] [Related]
5. Acute toxicity in definitive versus postprostatectomy image-guided radiotherapy for prostate cancer.
Cheng JC; Schultheiss TE; Nguyen KH; Wong JY
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):351-7. PubMed ID: 18164841
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: analysis of acute toxicity.
Jani AB; Su A; Milano MT
Urology; 2006 Jan; 67(1):147-51. PubMed ID: 16413351
[TBL] [Abstract][Full Text] [Related]
7. Impact of hormone therapy on acute radiotherapy toxicity in the treatment of prostate cancer.
Jani AB; Gratzle J; Myers M
Prostate Cancer Prostatic Dis; 2005; 8(3):224-8. PubMed ID: 15983626
[TBL] [Abstract][Full Text] [Related]
8. [Chronic gastrointestinal toxicity after external-beam radiation therapy for prostate cancer].
Sefrová J; Paluska P; Odrázka K; Jirkovský V
Klin Onkol; 2009; 22(5):233-41. PubMed ID: 19886362
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy combined with hormonal therapy (RT-HT) in prostate cancer patients with low, intermediate, and high risk of biochemical recurrence: perspective and therapeutic gain analysis.
Milecki P; Kwias Z; Martenka DJ
Neoplasma; 2007; 54(1):7-15. PubMed ID: 17203887
[TBL] [Abstract][Full Text] [Related]
10. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
[TBL] [Abstract][Full Text] [Related]
11. [The toxicity of anticancer chemotherapeutic agents to the genitourinary organs].
Machida T
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):956-8. PubMed ID: 2188615
[No Abstract] [Full Text] [Related]
12. Genitourinary malignancies.
Michaelson MD; Smith MR
Cancer Chemother Biol Response Modif; 2002; 20():471-91. PubMed ID: 12703221
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
